scPharmaceuticals Inc. (SCPH) Tops Q1 EPS by 6c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q1 EPS of ($0.36), $0.06 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $5.9 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Stifel Starts Victrex Plc. (VCT:LN) (VTXPF) at Buy
• Keurig Dr Pepper coffee chief to depart ahead of planned split